Category: Oncotarget

Oncotarget News

Testimonial: Dr. Dean Felsher

January 20, 2022

Below is a transcript of the testimonial from Dr. Dean Felsher from Stanford University School of Medicine, Departments of Medicine and Pathology and member of Oncotarget’s Founding Editorial Board,... read more

Dr. Brian Van Tine and Dr. Charles Schutt from Washington University in St. Louis

Oncotarget

Behind the Study: Genomic, Neoantigen Evolution in Head, Neck Cancer

January 10, 2022

Dr. Brian Van Tine and Dr. Charles Schutt from Washington University in St. Louis discuss their 2021 research published by Oncotarget, entitled, “Genomic and neoantigen evolution from... read more

Oncotarget

Open-Access Oncotarget Shifts to Continuous Publishing

January 6, 2022

As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous publishing.—BUFFALO, NY, January 6, 2022 – Since its inception in 2010, Oncotarget ... read more

Oncotarget

Behind the Study: Cholera Toxin and Age-associated Obesity

December 23, 2021

Dr. Susan Erdman from Massachusetts Institute of Technology (MIT) discusses the 2019 research paper she co-authored, entitled, “Consuming cholera toxin counteracts age-associated obesity.”Behind the Study is... read more

Oncotarget

Behind the Study: Metformin and Rapamycin as Maintenance Therapy

December 13, 2021

Dr. Katherine Bever from Johns Hopkins University discusses a research paper she co-authored that was published by Oncotarget, “An exploratory study of metformin with or without rapamycin as maintenance therapy... read more

Oncotarget

Testimonial: Dr. Jennifer Sheng

December 10, 2021

Dr. Jennifer Sheng from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center shares her experience publishing "Innovating and expanding weight loss strategies for breast cancer survivors" with Oncotarget.Dr. Jennifer... read more

Oncotarget

Testimonial: Dr. Gina Abdelaal

December 3, 2021

Dr. Gina Abdelaal from Northumbria University discusses her experience publishing “Reversing oncogenic transformation with iron chelation,” with Oncotarget.Dr. Gina AbdelaalI selected Oncotarget because I remember... read more

Oncotarget

Testimonial: Dr. Monica Varun Tyagi

November 25, 2021

Dr. Monica Varun Tyagi discusses her experience publishing “GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3,” with Oncotarget.Dr. Monica... read more

Oncotarget

Behind the Study: P4HA1 Protein and Colorectal Cancer

November 22, 2021

Dr. Michael Roehrl from Memorial Sloan Kettering Cancer Center describes the research paper he co-authored that was published by Oncotarget on February 25, 2020, entitled, “Prolyl 4-hydroxylase... read more

Oncotarget

Testimonial: Dr. Michael Roehrl

November 19, 2021

Dr. Michael Roehrl from the Department of Pathology, Memorial Sloan Kettering Cancer Center discusses his experience while publishing the paper, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal... read more